15.30
-0.03 (-0.16%)
| Previous Close | 15.32 |
| Open | 15.10 |
| Volume | 256,868 |
| Avg. Volume (3M) | 463,519 |
| Market Cap | 1,989,359,488 |
| Price / Earnings (TTM) | 12.75 |
| Price / Earnings (Forward) | 35.21 |
| Price / Sales | 7.14 |
| Price / Book | 4.48 |
| 52 Weeks Range | |
| Earnings Date | 21 Aug 2024 - 22 Aug 2024 |
| Profit Margin | 60.66% |
| Operating Margin (TTM) | 16.71% |
| Diluted EPS (TTM) | 1.02 |
| Quarterly Revenue Growth (YOY) | -61.30% |
| Quarterly Earnings Growth (YOY) | -83.20% |
| Current Ratio (MRQ) | 25.42 |
| Operating Cash Flow (TTM) | 119.51 M |
| Levered Free Cash Flow (TTM) | 98.45 M |
| Return on Assets (TTM) | 59.56% |
| Return on Equity (TTM) | 75.51% |
Market Trend
| Short Term | Medium Term | ||
| Industry | Biotechnology (AU) | Mixed | Mixed |
| Biotechnology (Global) | Mixed | Mixed | |
| Stock | NEUREN FPO NZ [NEU] | - | - |
AIStockmoo Score
| Analyst Consensus | 0.0 |
| Insider Activity | NA |
| Price Volatility | 2.0 |
| Technical Moving Averages | 0.0 |
| Technical Oscillators | -2.5 |
| Average | -0.13 |
|
Neuren Pharmaceuticals Ltd is a biopharmaceutical company, which engages in the development of new therapies for brain injury, neurodevelopment disorders. Its drugs target symptoms resulting from acute traumatic brain injury, as well as symptoms of chronic conditions, such as Rett syndrome and Fragile X syndrome. The Group has two reportable operating segments, Commercial Products and Research and Development. It derives maximum revenue from Commercial Products. |
|
| Sector | Healthcare |
| Industry | Biotechnology |
| Investment Style | Small Growth |
| % Held by Insiders | 13.29% |
| % Held by Institutions | 18.05% |
No data within this time range.
No data within this time range.
The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.
Portfolio
| Realized Profit | - |
| Unrealized Profit | - |
| Dividend Received 2025 | - |
| Total Profit | - |
| Avg. Return | - |
| Quantity (Buy) | - |
| Avg. Price (Buy) | - |
| Quantity (Sold) | - |
| Avg. Price (Sold) | - |